424 related articles for article (PubMed ID: 15894653)
41. [Mammographic breast density and breast cancer risk during HRT].
Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
[TBL] [Abstract][Full Text] [Related]
42. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
43. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
44. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
LeBlanc ES; Viscoli CM; Henrich JB
J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
[TBL] [Abstract][Full Text] [Related]
45. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
[TBL] [Abstract][Full Text] [Related]
46. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
47. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
48. [THE EFFECTS OF HORMONAL REPLACEMENT THERAPY (HRT) ON MAMMOGRAPHIC BREAST DENSITY AND ABNORMAL MAMMOGRAMS PROMPTING FURTHER INVESTIGATION].
Barda L; Nevler A; Rosin D; Shabtai EL; Gutman M; Shabtai M
Harefuah; 2019 Apr; 158(4):239-243. PubMed ID: 31032556
[TBL] [Abstract][Full Text] [Related]
49. Use of hormone therapy and isoflavones and mammographic density in Spain.
Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
[TBL] [Abstract][Full Text] [Related]
50. Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study.
Baines CJ; Vidmar M; McKeown-Eyssen G; Tibshirani R
Cancer; 1997 Aug; 80(4):720-4. PubMed ID: 9264355
[TBL] [Abstract][Full Text] [Related]
51. [Effect of hormone replacement therapy on the mammographic density of the female breast].
Egyed Z; Péntek Z; Magyar Z
Magy Onkol; 2005; 49(4):319-21, 323-5. PubMed ID: 16518476
[TBL] [Abstract][Full Text] [Related]
52. Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy.
Myles JP; Salmininen T; Duffy SW; Prevost TC; Day NE; Hakama M
Breast; 2004 Feb; 13(1):56-60. PubMed ID: 14759717
[TBL] [Abstract][Full Text] [Related]
53. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
Strand F; Humphreys K; Eriksson M; Li J; Andersson TM; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Int J Cancer; 2017 Jan; 140(1):34-40. PubMed ID: 27615710
[TBL] [Abstract][Full Text] [Related]
55. [Impact of replacement hormone therapy in menopause on breast radiologic density and possible complications of mammography in the assessment of breast masses].
Ciatto S; Bonardi R; Zappa M
Radiol Med; 2001; 101(1-2):39-43. PubMed ID: 11360750
[TBL] [Abstract][Full Text] [Related]
56. Effects of hormone replacement therapy on mammographic findings.
Bülbül NH; Ozden S; Dayicioglu V
Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
[TBL] [Abstract][Full Text] [Related]
57. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
[TBL] [Abstract][Full Text] [Related]
58. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
[TBL] [Abstract][Full Text] [Related]
59. Hormone replacement therapy and breast density changes.
Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
[TBL] [Abstract][Full Text] [Related]
60. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
